Just over a year ago, Change Healthcare was the target of the largest medical data breach in U.S. history. The cyberattack impacted over 190 million people in the U.S. and halted the healthcare technology company’s systems, causing months of outages.
Change Healthcare provides solutions and services to hundreds of thousands of healthcare providers nationwide and processes billions of transactions each year. This attack had a massive ripple effect, preventing transactions, payments, and
Read More
Most Popular
Medtronic to Separate Diabetes Business into New Standalone Company
What You Should Know:
- Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company ("New Diabetes Company").
- The move aims to create a more focused Medtronic, with a simplified portfolio concentrated on high-margin growth markets, while simultaneously establishing a scaled, independent leader in the diabetes sector.
- The separation is expected to be completed within 18 months through a series of
Read More
HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced it is taking immediate action to implement President Donald J. Trump’s Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.”
- Under the leadership of President Trump, HHS Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz, the Department has outlined specific targets for
Read More
Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services
What You Should Know:
- Regeneron Pharmaceuticals, Inc. announced it has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe Holding Co.
- Regeneron plans to acquire 23andMe’s Personal Genome Service® (PGS), Total Health and Research Services business lines, along with its extensive Biobank and associated assets, for $256 million.
- Under the terms of the proposed acquisition, Regeneron intends for 23andMe to continue all
Read More
CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft
What You Should Know:
- CureIS Healthcare, Inc., a company specializing in information technology solutions for the healthcare industry, has filed a lawsuit against EHR giant Epic Systems Corporation.
- The complaint, lodged in the U.S. District Court for the Northern District of California on May 13, 2025, accuses Epic of engaging in a multifaceted scheme to unlawfully stifle competition, interfere with CureIS's business and customer relationships, misappropriate trade secrets, and
Read More
The Evolving Physician Advisor: From UM to Value-Based Care & AI
In today’s complex healthcare landscape, Physician Advisors (PAs) play an increasingly vital role in ensuring hospitals and health systems function smoothly, efficiently, and with a focus on patient-centered care. As healthcare spending continues to rise, the need for professionals who can effectively navigate the intersection of clinical practice and financial stewardship has never been greater.
What is
Read More
UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO
What You Should Know:
- UnitedHealth Group today announced a significant leadership transition, with Stephen J. Hemsley being re-appointed as its chief executive officer, effective immediately.
- Hemsley, who previously led the company as CEO from 2006 to 2017 and will remain chairman of the company’s Board of Directors, steps in as Andrew Witty has decided to step down as CEO for personal reasons. Witty will continue to support the transition by serving as a senior adviser to
Read More
Omada Health Files for IPO
What You Should Know:
- Virtual care company Omada Health filed for an initial public offering (IPO) on Friday, according to the SEC filing.
- Founded in 2012, Omada specializes in virtual care programs designed to support patients managing chronic conditions such as prediabetes, diabetes, and hypertension.
- The company describes its unique approach as a “between-visit care model,” aiming to complement the broader healthcare ecosystem by providing ongoing support to
Read More
MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners
What You Should Know:
- MedTech Breakthrough, an independent market intelligence organization dedicated to recognizing top-tier companies, technologies, and products in the global health and medical technology sector, today proudly announced the winners of its 9th annual awards program.
- The 2025 awards highlight the groundbreaking technologies and companies that are spearheading innovation and exemplifying the best in digital health and medical technology solutions
Read More
Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density
What You Should Know:
- Osteoboost Health announced the nationwide availability of Osteoboost, a groundbreaking prescription medical device. Osteoboost aims to provide hope for millions diagnosed with low bone density, helping to reduce the risk of fractures that can severely impact mobility and independence.
- As the first and only FDA-cleared device of its kind for low bone density, Osteoboost introduces a novel, protective, and preventative approach to bone health, offering a new
Read More
